CCN(CC)CCCC(C)Nc1cc(/C=C/c2ccc(Cl)cc2)nc2cc(N(C)C)ccc12
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?